JPJakub Przyłuski

Jakub Przyłuski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jakub Przyłuski has a total of 53 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Incidence and Predictors of Clinically Significant Bleedings after Transcatheter Left Atrial Appendage Closure

    by Kamil Zieliński, Radosław Pracoń, Marek Konka, Mariusz Kruk, Cezary Kępka, Piotr Trochimiuk, Mariusz Dębski, Edyta Kaczmarska, Jakub Przyłuski, Ilona Kowalik, et al.

    Background: Transcatheter left atrial appendage closure (LAAC) is performed in patients unsuitable for long-term anticoagulation, predominantly due to prior bleeding events. The study aimed to investigate the incidence and predictors of clinically significant bleeding (CSB) post-LAAC. Methods: Consecutive patients after LAAC with an Amplatzer or WATCHMAN device were analyzed (05.2014–11.2019). Bleeding was classified as CSB when associated with at least one of the following: death, ≥2 g/dL hemoglobin drop, ≥2 blood units transfusion, critical anatomic site, or hospitalization/invasive procedure. Results: Among 195 patients (age 74 (68–80), 43.1% females, HAS-BLED score 2.0 (2.0–3.0)), during median follow-up of 370 (IQR, 358–392) days, there were 15 nonprocedural CSBs in 14 (7.2%) patients. Of those, 9 (60.0%) occurred during postprocedural dual antiplatelet therapy (DAPT) (median 46 (IQR: 16–60) days post-LAAC) vs. 6 (40%) after DAPT discontinuation (median 124 (81–210) days post-LAAC), translating into annualized CSB rates of 14.0% (per patient-year on DAPT) vs. 4.6% (per patient-year without DAPT). In 92.9% (13/14) of patients, the post-LAAC nonprocedural CSB was a recurrence from the same site as bleeding pre-LAAC. In the multivariable model, admission systolic blood pressure (SBP) > 127 mmHg (HR = 10.73, 1.37–84.26, p = 0.024), epistaxis history (HR = 5.84, 1.32–25.89, p = 0.020), permanent atrial fibrillation (AF) (HR = 4.55, 1.20–17.20, p = 0.025), and prior gastrointestinal bleeding (HR = 3.35, 1.01–11.08, p = 0.048) predicted post-LAAC CSB. Conclusions: Nonprocedural CSBs after LAAC, with a similar origin as the pre-LAAC bleedings, were observed predominantly during postprocedural DAPT and predicted by elevated admission SBP, prior epistaxis, permanent AF, and gastrointestinal bleeding history. Whether a more reserved post-LAAC antiplatelet regimen and stringent blood pressure control may improve LAAC outcomes remains to be studied.


  • Comparison of safety and efficacy of paclitaxel-eluting stents with durable versus biodegradable polymer implanted in saphenous vein graft lesions. Nine-month angiographic and intravascular ultrasound follow-up

    by Jerzy Pregowski, Adam Witkowski, Zbigniew Chmielak, Łukasz Kalińczuk, Andrzej Ciszewski, Maciej Karcz, Jakub Przyłuski, Jan Jastrzebski, Rafał Wolny, Mieczysław Dziarmaga

    Cel: Porównanie skuteczności i bezpieczeństwa implantacji stentów uwalniających paklitaksel z polimeru biodegradowalnego (Luc Chopin 2 stent) i trwałego (Taxus Liberté stent) w żylnych pomostach aortalno-wieńcowych ( saphenous vein grafts – SVGs). Materiał i metody: Do...

  • Open Access

    Relation of subacute stent thrombosis and resistance to acetylsalicylic acid and clopidogrel in patients with acute coronary syndrome. Insights from the ANIN Myocardial Infarction Registry

    by Jerzy Pręgowski, Jakub Przyłuski, Maciej Karcz, Bożena Norwa-Otto, Mariusz Kruk, Łukasz Kalińczuk, Paweł Tyczyński, Michał Ciszewski, Witold Rużyłło, Dariusz Sitkiewicz, et al.

    Wstęp : Zakrzepica w stencie (ZS) stanowi jedno z najcięższych powikłań kardiologii interwencyjnej. Cel : Ocena związku pomiędzy odpowiedzią płytek krwi na kwas acetylosalicylowy (ASA) i klopidogrel a wystąpieniem podostrej ZS u chorych z wywiadem ostrego zespołu wieńcowego...

    • 1 September 2009
      • Vol. 15  (9) , CR477-83

    Sodium level on admission and in-hospital outcomes of STEMI patients treated with primary angioplasty: the ANIN Myocardial Infarction Registry.

    by Mariusz Klopotowski, Mariusz Kruk, Jakub Przyluski, Lukasz Kalinczuk, Jerzy Pregowski, Pawel Bekta, Lukasz A Malek, Cezary Kepka, Andrzej Ciszewski, Zbigniew Chmielak, et al.

    Hyponatremia is a common electrolyte disorder reported to be a predictor of poor prognosis among hospitalized patients, but individuals with high levels also tend to have less favorable outcomes. This study investigated whether sodium level on admission is predictive of in-hospital outcome in patients with ST-elevation myocardial infarction (STEMI) treated with primary angioplasty. Included were 1858 patients admitted with STEMI for primary angioplasty. Sodium level was measured on admission and analyzed as hypo- versus normonatremia and by grouping patients into sodium quintiles. The relationships between sodium level and in-hospital mortality as well as the composite of death or heart failure were assessed. Ninety-six patients had hyponatremia on admission. The hypo- and normonatremic groups were comparable with respect to baseline characteristics and in-hospital management. Hyponatremics had higher rates of in-hospital mortality (13.5% vs. 3.8%, p<0.001) composite of death and heart failure (27.8% vs. 18.4%, p=0.022). After adjustment for covariates, hyponatremia independently correlated with in-hospital mortality (HR: 3.89, 95%CI: 1.59-9.56, p=0.003) and the combined endpoint (HR: 1.73, 95%CI: 1.01-2.99, p=0.047). Patients in the lowest and highest sodium quintiles were 3.27 (95%CI: 1.34-8.02, p=0.009) and 2.65 (95%CI: 1.07-6.60, p=0.036) times more likely to die during hospitalization than those in the 2nd quintile (best survival). In the adjusted model, only patients in the lowest quintile had significantly increased risk of in-hospital death (HR: 6.35, 95%CI: 1.83-21.72, p=0.004). Hyponatremia is a simple laboratory marker independently associated with increased risk of death in STEMI patients treated with primary angioplasty.


    • 1 August 2008
      • Vol. 66  (8) , 828

    Primary angioplasty in patients > or = 75 years old with ST-elevation myocardial infarction - one-year follow-up results.

    by Andrzej Ciszewski, Maciej Karcz, Cezary Kepka, Paweł Bekta, Ewa Ksiezycka, Jakub Przyłuski, Artur Debski, Adam Witkowski, Witold Ruzyłło

    Efficacy and safety of primary percutaneous coronary angioplasty (PCI) in elderly patients with acute ST-elevation myocardial infarction (STEMI) have not yet been definitely established because these patients were usually excluded from large randomised trials. To evaluate in-hospital and one-year outcome after primary PCI in elderly patients, and to assess clinical characteristics of this group. The study population included 1061 consecutive STEMI patients, mean age 60.6+/-17 years, treated with primary PCI. Clinical characteristics and results of 127 patients aged > or = 75 years were compared to the younger group. Elderly patients were more frequently female (48.4 vs. 23.6%, p or = 75 years. Primary PCI in older STEMI patients is associated with a favourable in-hospital and one-year outcome, although inferior to that seen in younger patients. The in-hospital complication rate is similar in the elderly and in younger patients.


    • 1 January 2007
      • Vol. 65  (1) , 1

    Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

    by Łukasz Kalińczuk, Jakub Przyłuski, Maciej Karcz, Joanna Petryka, Edyta Kaczmarska, Paweł Bekta, Cezary Kepka, Mariusz Kruk, Jerzy Pregowski, Jacek Kadziela, et al.

    TIMI scale is commonly used for angiographic assessment of reperfusion effectiveness and early risk stratification in patients treated with primary angioplasty for ST-elevation myocardial infarction (STEMI). Since ST-resolution analysis allows a noninvasive insight into the reperfusion status at the myocardial tissue level, it may be a better predictor of outcome after primary angioplasty. To compare the prognostic value of the reperfusion effectiveness evaluation based on either the epicardial blood flow assessment according to the TIMI scale, or ST-segment resolution analysis in patients treated with primary coronary angioplasty for STEMI. 324 consecutive patients treated within 12 hours from the pain onset were studied. Based on the analysis of maximal ST-segment elevation/depression identified in a single ECG lead recorded after the procedure (maxSTE), patients were classified into groups of high versus medium/low risk. Independently, distinguished were groups with restored normal (TIMI 3) and abnormal (TIMI 0-2) final blood flow in infarct related artery. The 30-day and one-year mortality rates were higher in the high-risk maxSTE group (25% of all patients) than in the other patients (14.8% vs. 2.5%, p<0.001 and 18.5% vs. 5.4%, p<0.001 respectively). In subjects (82%) with restored TIMI grade 3 blood flow, mortality at one-month and one-year was lower than in the group with abnormal final blood flow (3.1% vs. 15.6%, p=0.001 and 6.2% vs. 18.8%, p=0.005). Comparison in multivariate analysis revealed that maxSTE stratification but not final TIMI grade assessment remained an independent predictor of both, 30-day and one-year mortality (high vs. medium/low-risk category; OR 5.3, 95% CI 1.6-16.7, p=0.005, and OR 3.3, 95% CI 1.4-7.8, p=0.007, respectively). Furthermore, maxSTE proved to stratify the risk of death even in subgroup of patients with restored normal blood flow (OR 6.2, 95% CI 1.4-27.8, p=0.016, and OR 3.0, 95% CI 1.1-8.7, p=0.039, respectively). Analysis of extent of maximal ST-segment elevation or depression identified in a single ECG lead after primary coronary angioplasty allows better prognosis of subsequent 30-day and one-year mortality than the assessment of final epicardial blood flow, stratifying risk of death even in a subgroup of patients with restored normal blood flow.

  • Comparison of Different Methods of ST Segment Resolution Analysis for Prediction of 1‐Year Mortality after Primary Angioplasty for Acute Myocardial Infarction

    by Jakub Przyluski, Maciej Karcz, Łukasz Kalińczuk, Mariusz Kruk, Jerzy Prȩgowski, Edyta Kaczmarska, Joanna Petryka, Paweł Bekta, Tomasz Deptuch, Cezary Kȩpka, et al.

    Background: Resolution of ST segment elevation corresponds with myocardial tissue reperfusion and correlates with clinical outcome after ST elevation myocardial infarction. Simpler method evaluating the extent of maximal deviation persisting in a single ECG lead was an even stronger mortality predictor. Our aim was to evaluate and compare prognostic accuracy of different methods of ST segment elevation resolution analysis after primary percutaneous coronary intervention (PCI) in a real‐life setting. Methods: Paired 12‐lead ECGs were analyzed in 324 consecutive and unselected patients treated routinely with primary PCI in a single high‐volume center. ST segment resolution was quantified and categorized into complete, partial, or none, upon the (1) sum of multilead ST elevations (sumSTE) and (2) sum of ST elevations plus reciprocal depressions (sumSTE+D); or into the low‐, medium‐, and high‐risk groups by (3) the single‐lead extent of maximal postprocedural ST deviation (maxSTE). Results: Complete, partial, and nonresolution groups by sumSTE constituted 39%, 40%, and 21% of patients, respective groups by sumSTE+D comprised 40%, 39%, and 21%. The low‐, medium‐, and high‐risk groups constituted 43%, 32%, and 25%. One‐year mortality rates for rising risk groups by sumSTE were 4.7%, 10.2%, and 14.5% (P = 0.049), for sumSTE+D 3.8%, 9.6%, and 17.6% (P = 0.004) and for maxSTE 5.1%, 6.7%, and 18.5% (P = 0.001), respectively. After adjustment for multiple covariates only maxSTE (high vs low‐risk, odds ratio [OR] 3.10; 95% confidence interval [CI] 1.11–8.63; P = 0.030) and age (OR 1.07; 95% CI 1.02–1.11; P = 0.002) remained independent predictors of mortality. Conclusions: In unselected population risk stratifications based on the postprocedural ST resolution analysis correlate with 1‐year mortality after primary PCI. However, only the single‐lead ST deviation analysis allows an independent mortality prediction.


    • 1 June 2003
      • p. IV36-43

    [Results of treatment procedure for patients with acute myocardial infarction or acute coronary syndrome without ST segment elevation. Summary of the entire first year period of invasive cardiology at the Cadiology Institute in Warsaw-Anin].

    by Maciej Karcz, Cezary Kepka, Paweł Bekta, Adam Witkowski, Anna Konopka, Zbigniew Chmielak, Marcin Demkow, Artur Debski, Andrzej Ciszewski, Michał Ciszewski, et al.

    • 1 May 2003
      • Vol. 58  (5) , 366

    Acute myocardial infarction complicated by cardiogenic shock. In-hospital and mid-term results of invasive treatment in the National Institute of Cardiology, Warsaw-Anin.

    by Maciej Karcz, Paweł Bekta, Cezary Kepka, Adam Witkowski, Anna Konopka, Zbigniew Chmielak, Marcin Demkow, Artur Debski, Andrzej Ciszewski, Michał Ciszewski, et al.

    Mortality in acute myocardial infarction (MI) complicated by cardiogenic shock approaches 90%, regardless of the type of pharmacological treatment. To assess in-hospital and mid-term results of invasive treatment of patients with acute MI with ST segment elevation (STEMI) complicated by cardiogenic shock. From a prospective registry of all patients admitted to our institution for urgent coronary angiography due to acute coronary syndrome between February 2001 and June 2002, patients with STEMI, symptom duration up to 12 hours and cardiogenic shock diagnosed on admission were identified. The in-hospital and mid-term outcome of 37 patients (mean age 65 years, range 54-77, 68% of males) treated with primary percutaneous coronary intervention (PCI) was analysed. Of the 41 patients with STEMI and cardiogenic shock, total occlusion or critical stenosis of a coronary artery were found in 38 patients. One patient with the occlusion of three main coronary arteries underwent urgent surgical revascularisation and remains alive after an 18-month follow-up. In the remaining 37 patients primary PCI of an infarct-related artery was performed (stent implantation in 70%, abciximab administration in 54%) which restored normal blood flow (TIMI grade 3 flow) in 54% of subjects. In patients with TIMI grade 3 flow the in-hospital mortality was 25%. Of the whole PCI-treated group, 18 (48.6%) patients died during stay in our institution, an additional two - after transfer to another hospital, and one - during a 19-month follow-up period. The remaining 16 patients remain alive (median follow-up of 8 months). Invasive treatment of patients with STEMI complicated by cardiogenic shock significantly reduces mortality in this high-risk population. The mid-term results in patients discharged from hospital are good. Invasive treatment of acute MI should be accessible for all patients with extensive acute MI.